Search

Search Constraints

You searched for: Author/Creator Mi, Jinye

Search Results

2. A novel ROS1 G2032 K missense mutation mediates lorlatinib resistance in a patient with ROS1-rearranged lung adenocarcinoma but responds to nab-paclitaxel plus pembrolizumab. (May 2020)